Transcriptional regulation of cyclo-oxygenase expression: Three pillars of control

International Journal of Immunopathology and Pharmacology

Volumn 16, Issue 2 SUPPL., 2003, Pages 59-67

  Ramsay, R G ^a   Ciznadija, D ^a   Vanevski, M ^a   Mantamadiotis, T ^a  

^a NONE

Author keywords

c Myb; COX 1; COX 2; CREB; NF kappaB; Wnt

Indexed keywords

ACETYLSALICYLIC ACID; CCAAT ENHANCER BINDING PROTEIN BETA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYCLOOXYGENASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIM PROTEIN; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEAR FACTOR; PHOSPHOPROTEIN; PROSTAGLANDIN SYNTHASE; PROTEIN C MYB; PROTEIN PCOX 1A; PROTEIN SUBUNIT; PROTEIN TCF4; SPLICED LEADER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ALTERNATIVE RNA SPLICING; ARTHRITIS; COLORECTAL CANCER; COMPLEMENT INHIBITION; COX GENE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; EXON; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; INFECTION; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; RNA STABILITY; STEROID ANALYSIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BASE SEQUENCE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TRANSCRIPTION, GENETIC;

EID: 0142089889     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Hochberg M.C. 2002. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective. Am. J. Manag. Care. 8:S502.
2. Yamamoto D.S. and P.H. Viale. 2003. Cyclooxygenase-2: from arthritis treatment to new indications for the prevention and treatment of cancer. Clin. J. Oncol. Nurs. 7:21.
3. Jackson C.G. 2001. Therapeutic potential of COX-2 inhibitors in arthritis. Expert Opin. Investig. Drugs. 10:1317.
4. Xu X.M., L. Sansores-Garcia, X.M. Chen, N. Matijevic-Aleksic, M. Du and K.K. Wu. 1999. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc. Natl Acad. Sci. USA. 96:5292.
5. Sano H., Y. Kawahito, R.L. Wilder, A. Hashiramoto, S. Mukai, K. Asai, S. Kimura, H. Kato, M. Kondo and T. Hla. 1995. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:3785.
6. Tanabe T. and N. Tohnai. 2002. Cyclooxygenase isozymes and their gene s tructures and expression. Prostaglandins Other Lipid Mediat. 68:95.
7. Wang L.H., A. Hajibeigi, X.M. Xu, D. Loose-Mitchell and K.K. Wu. 1993. Characterization of the promoter of human prostaglandin H synthase-1 gene. Biochem. Biophys Res. Commun. 190:406.
8. Xu X.M., J.L. Tang, X. Chen, L.H. Wang and K.K. Wu. 1997. Involvement of two Sp1 elements in basal endothelial prostaglandin H synthase-1 promoteractivity. J. Biol. Chem. 272:6943.
9. Taniura S., H. Kamitani, T. Watanabe and T.E. Eling. 2002. Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. J. Biol. Chem. 277:16823.
10. Kitzler J., E. Hill, R. Hardman, N. Reddy, R. Philpot and T.E. Eling. 1995. Analysis and quantitation of splicing variants of the TPA-inducible PGHS-1 mRNA in rat tracheal epithelial cells. Arch. Biochem. Biophys. 316:856.
11. Ueda N., R. Yamashita, S. Yamamoto and K. Ishimura. 1997. Induction of cyclooxygenase-1 in a human megakaryoblastic cell line (CMK) differentiated by phorbol ester. Biochim. Biophys Acta. 1344:103.
12. Maldve R.E., Y. Kim, S.J. Muga and S.M. Fischer. 2000. Prostaglandin E(2) regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors. J. Lipid. Res. 41:873.
13. Inoue H., C. Yokoyama, S. Hara, Y. Tone and T. Tanabe. 1995. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J Biol Chem. 270:24965.
14. Tang Q., W. Chen, M.S. Gonzales, J. Finch, H. Inoue and G.T. Bowden. 2001. Role of cyclic AMP responsive element in the UVB induction of cyclooxygenase-2 transcription in human keratinocytes. Oncogene 20:5164.
15. Mestre J.R., P.J. Mackrell, D.E. Rivadeneira, P.P. Stapleton, T. Tanabe and J.M. Daly. 2001. Redundancy in the signaling pathways and promoter elements regulating cyclooxygenase-2 gene expression in endotoxin-treated macrophage/monocytic cells. J. Biol. Chem. 276:3977.
16. Liu W., N. Reinmuth, O. Stoeltzing, A.A. Parikh, C. Tellez, S. Williams, Y.D. Jung, F. Fan, A. Takeda, M. Akagi, M. Bar-Eli, G.E. Gallick and L.M. Ellis. 2003. Cyclooxygenase-2 Is Up-Regulated by Interleukin-1 beta in Human Colorectal Cancer Cells via Multiple Signaling Pathways. Cancer Res. 63:3632.
17. Appleby S.B., A. Ristimaki, K. Neilson, K. Narko and T. Hla. 1994. Structure of the human cyclo-oxygenase-2 gene. Biochem J. 302:723.
18. Inoue H. and T. Tanabe. 1998. Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem. Biophys Res. Commun. 244:143.
19. von Knethen A., D. Callsen and B. Brune. 1999. NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol. Biol. Cell. 10:361
20. Nanayama T., S. Hara, H. Inoue, C. Yokoyama and T. Tanabe. 1995. Regulation of two isozymes of prostaglandin endoperoxide synthase and thromboxane synthase in human monoblastoid cell line U937. Prostaglandins 49:371.
21. Riese J., T. Hoff, A. Nordhoff, D.L. DeWitt, K. Resch and V. Kaever. 1994. Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation. J. Leukoc. Biol. 55:476
22. Kojima M., T. Morisaki, K. Izuhara, A. Uchiyama, Y. Matsunari, M. Katano and M. Tanaka. 2000. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation. Oncogene. 19:1225.
23. Maihofner C., M.P. Charalambous, U. Bhambra, T. Lightfoot, G. Geisslinger and N.J. Gooderham. 2003. Expression of cyclooxygenase-2 parallels expression of interleukin-1 beta, interleukin-6 and NF-kappaB in human colorectal cancer. Carcinogenesis. 24:665.
24. Dejardin E., V. Deregowski, M. Chapelier, N. Jacobs, J. Gielen, M.P. Merville and V. Bours. 1999. Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells. Oncogene. 18:2567
25. Shao J., H. Sheng, H. Inoue, J.D. Morrow and R.N. DuBois. 2000. Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J. Biol. Chem. 275:33951.K
26. Wong B.C., X. Jiang, X.M. Fan, M.C. Lin, S.H. Jiang, S.K. Lam and H.F. Kung. 2003. Suppression of RelA/ p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer. Oncogene. 22:1189.
27. Stark L.A., F.V. Din, R.M. Zwacka and M.G. Dunlop. 2001. Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. Faseb J. 15:1273.
28. Ramsay R.G., A. Friend, Y. Vizantios, R. Freeman, C. Sicurella, F. Hammett, J. Armes and D. Venter. 2000. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB. Cancer Res. 60:1805.
29. Ramsay R.G., M.A. Thompson, J.A. Hayman, G. Reid, T.J. Gonda and R.H. Whitehead. 1992. Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa. Cell Growth Differ. 3:723.
30. Thompson M.A., M.A. Rosenthal, S.L. Ellis, A.J. Friend, M.I. Zorbas, R.H. Whitehead and R.G. Ramsay. 1998. c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression. Cancer Res. 158:5168.
31. Glinghammar B. and J. Rafter. 2001. Colonic luminal contents induce cyclooxygenase 2 transcription in human colon carcinoma cells. Gastroenterology. 120:401
32. Crew T.E., D.J. Elder and C. Paraskeva. 2000. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate. Carcinogenesis. 21:69.
33. Billack B., D.E. Heck, T.M. Mariano, C.R. Gardner, R. Sur, D.L. Laskin and J.D. Laskin. 2002. Induction of cyclooxygenase-2 by heat shock protein 60 in macrophages and endothelial cells. Am. J. Physiol. Cell Physiol. 283:C1267.
34. Eliopoulos A.G., C.D. Dumitru, C.C. Wang, J. Cho and P.N. Tsichlis. 2002. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J. 21:4831.
35. Miller C., M. Zhang, Y. He, J. Zhao, J.P. Pelletier, J. Martel-Pelletier and J.A. Di Battista. 1998. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. J. Cell Biochem. 69:392.
36. Peifer M. and P. Polakis. 2000. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science. 287:1606.
37. Howe L.R., H.C. Crawford, K. Subbaramaiah, J.A. Hassell, A.J. Dannenberg and A.M. Brown. 2001. PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. J. Biol. Chem. 276:20108.
38. Dimberg J., A. Hugander, A. Sirsjo and P. Soderkvist. 2001. Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer. Anticancer Res. 21:911.
39. Howe L.R., K. Subbaramaiah, W.J. Chung, A.J. Dannenberg and A.M. Brown. 1999. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res. 59:1572.
40. Haertel-Wiesmann M., Y. Liang, W.J. Fantl and L.T. Williams. 2000. Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J. Biol. Chem. 275:32046.
41. Araki Y., S. Okamura, S.P. Hussain, M. Nagashima, P. He, M. Shiseki, K. Miura and C.C. Harris. 2003. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res. 63:728.
42. Vogiagis D., W. Brown, E.M. Glare and P.E. O'Brien. 2001. Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels. Carcinogenesis. 22:869.
43. Vogiagis D., E.M. Glare, A. Misajon, W. Brown and P.E. O'Brien. 2000. Cyclooxygenase-1 and an alternatively spliced mRNA in the rat stomach: effects of aging and ulcers. Am. J. Physiol. Gastrointest. Liver Physiol. 278:G820.
44. Chandrasekharan N.V., H. Dai, K.L. Roos, N.K. Evanson, J. Tomsik, T.S. Elton and D.L. Simmons. 2002. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc. Natl Acad. Sci. USA. 99:13926.
45. Smith W.L., D.L. DeWitt and R.M. Garavito. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69:145.
46. Gou Q., C.H. Liu, P. Ben-Av and T. Hla. 1998. Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3′-untranslated region. Biochem Biophys Res Commun. 242:508.
47. Dean J.L., M. Brook, A.R. Clark and J. Saklatvala. 1999. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274:264.
48. Ridley S.H., J.L. Dean, S.J. Sarsfield, M. Brook, A.R. Clark and J. Saklatvala. 1998. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett. 439:75.
49. Lasa M., M. Brook, J. Saklatvala and A.R. Clark. 2001. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol. Cell. Biol. 21:771.
50. Jang B.C., T. Sanchez, H.J. Schaefers, O.C. Trifan, C.H. Liu, C. Creminon, C.K. Huang and T. Hla. 2000. Serum withdrawal-induced post-transcriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase. J. Biol. Chem. 275:39507.
51. Lasa M., K.R. Mahtani, A. Finch, G. Brewer, J. Saklatvala and A.R. Clark. 2000. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell. Biol. 20:4265.
52. Masferrer J.L. and K. Seibert. 1994. Regulation of prostaglandin synthesis by glucocorticoids. Receptor 4:25.
53. Lee, S.H., E. Soyoola, P. Chanmugam, S. Hart, W. Sun, H. Zhong, S. Liou, D. Simmons, and D. Hwang. 1992. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267:25934.
54. Newman S.P., R.J. Flower and J.D. Croxtall. 1994. Dexamethasone suppression of IL-1 beta-induced cyclooxygenase 2 expression is not mediated by lipocortin-1 in A549 cells. Biochem. Biophys. Res. Commun. 202:931.
55. Barrios-Rodiles M., G. Tiraloche and K. Chadee. 1999. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha. J. Immunol. 163:963.
56. Dixon D.A., C.D. Kaplan, T.M. McIntyre, G.A. Zimmerman and S.M. Prescott. 2000. Posttranscriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J. Biol. Chem. 275:11750.
57. Ristimaki A., K. Narko and T. Hla. 1996. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcriptisoforms by dexamethasone: evidence for posttranscriptional regulation. Biochem. J. 318 (Pt 1):325.
58. Shaul P.W., M.C. Pace, Z. Chen and T.S. Brannon. 1999. Developmental changes in prostacyclin synthesis are conserved in cultured pulmonary endothelium and vascular smooth muscle. Am. J. Respir. Cell. Mol. Biol. 20:113.
59. Jun S.S., Z. Chen, M.C. Pace and P.W. Shaul. 1999. Glucocorticoids downregulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium. Circ. Res. 84:193.